Related Experiment Video
Updated: May 5, 2026

Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
AFG Ameliorates Diabetic Retinopathy through AMPK-Dependent Autolysosomal Pathway: From Network Pharmacology to In
Rui-Yi Hu1, Wenya Su1, Si-Min Qi2
1College of Chinese Medicinal Materials, Jilin Provincial International Joint Research Center for the Development and Utilization of Authentic Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.
Abstract:
Diabetic retinopathy (DR) is a sight-threatening microvascular complication of diabetes. This study investigates the protective effects and mechanisms of arginyl-fructosyl-glucose (AFG) (a hypoglycemic component from red ginseng) against DR. Utilizing network pharmacology and experimental models (HFD/STZ-induced mice and high-glucose-stimulated retinal cells), we demonstrate that AFG alleviates retinal injury by activating AMPK-driven autolysosome biogenesis. This core mechanism inhibits VEGF-mediated vascular hyperpermeability to preserve the blood-retinal barrier while also promoting autophagic flux, reducing lysosomal membrane permeabilization, and ultimately curtailing apoptosis. Our research results systematically clarify the various actions of AFG on DR, supporting its potential as a novel therapeutic candidate.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Diabetic Retinopathy
Diabetic Nephropathy

